Richard W I Cooke1. 1. School of Reproductive and Developmental Medicine, University of Liverpool, Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK. mc19@liv.ac.uk
Abstract
BACKGROUND AND OBJECTIVE: It has been suggested that fetal growth restriction (FGR) is associated with fetal maturation so that, compared with appropriately grown preterm infants, mortality and some neonatal morbidities may be reduced. The evidence for this is conflicting, and severe FGR has been shown to be harmful. In addition excessive growth has also been shown to be associated with poorer outcomes. As preterm infants are often also growth restricted, centiles for birth weights are distorted and may conceal the degree of growth restriction in a given infant. This study investigated whether using estimated fetal weights (EFW) might reveal the effects of hidden FGR. POPULATION AND METHODS: Using a 25-year database of preterm admissions to a single neonatal unit the ORs for mortality and neonatal morbidities for z scores for birth weight above and below the mean were computed and compared with those computed for z scores for EFW. RESULTS: In 7898 infants born at less than 35 weeks' gestation, the OR for mortality was lowest for birth weights between 1 SD and 3 SD above the mean, but was lowest for EFW between -2 SD and 0 SD below the mean. For periventricular haemorrhage, increasing FGR below the mean reduced the OR with both birth weight and EFW. Apparent reductions in OR for septicaemia, chronic lung disease, persistent ductus arteriosus and necrotising enterocolitis with birth weights of >1 SD above the mean were not seen with EFW. FGR of >-3 SD was associated with increased OR for necrotising enterocolitis with both birth weight and EFW. CONCLUSION: Using fetal growth rather than birth weight standards gives a better indication of the incidence and role of FGR in neonatal disease.
BACKGROUND AND OBJECTIVE: It has been suggested that fetal growth restriction (FGR) is associated with fetal maturation so that, compared with appropriately grown preterm infants, mortality and some neonatal morbidities may be reduced. The evidence for this is conflicting, and severe FGR has been shown to be harmful. In addition excessive growth has also been shown to be associated with poorer outcomes. As preterm infants are often also growth restricted, centiles for birth weights are distorted and may conceal the degree of growth restriction in a given infant. This study investigated whether using estimated fetal weights (EFW) might reveal the effects of hidden FGR. POPULATION AND METHODS: Using a 25-year database of preterm admissions to a single neonatal unit the ORs for mortality and neonatal morbidities for z scores for birth weight above and below the mean were computed and compared with those computed for z scores for EFW. RESULTS: In 7898 infants born at less than 35 weeks' gestation, the OR for mortality was lowest for birth weights between 1 SD and 3 SD above the mean, but was lowest for EFW between -2 SD and 0 SD below the mean. For periventricular haemorrhage, increasing FGR below the mean reduced the OR with both birth weight and EFW. Apparent reductions in OR for septicaemia, chronic lung disease, persistent ductus arteriosus and necrotising enterocolitis with birth weights of >1 SD above the mean were not seen with EFW. FGR of >-3 SD was associated with increased OR for necrotising enterocolitis with both birth weight and EFW. CONCLUSION: Using fetal growth rather than birth weight standards gives a better indication of the incidence and role of FGR in neonatal disease.
Authors: M J Simchen; M E Beiner; N Strauss-Liviathan; M Dulitzky; J Kuint; S Mashiach; E Schiff Journal: Am J Perinatol Date: 2000 Impact factor: 1.862
Authors: Stephen Jarvis; Svetlana V Glinianaia; Maria-Giulia Torrioli; Mary-Jane Platt; Maria Miceli; Pierre-Simon Jouk; Ann Johnson; Jane Hutton; Karla Hemming; Gudrun Hagberg; Helen Dolk; James Chalmers Journal: Lancet Date: 2003-10-04 Impact factor: 79.321
Authors: Iris G Streimish; Richard A Ehrenkranz; Elizabeth N Allred; T Michael O'Shea; Karl C K Kuban; Nigel Paneth; Alan Leviton Journal: Early Hum Dev Date: 2012-06-23 Impact factor: 2.079
Authors: Anthony A Sochet; Mark Ayers; Emilio Quezada; Katherine Braley; Jennifer Leshko; Ernest K Amankwah; James A Quintessenza; Jeffrey P Jacobs; Gul Dadlani Journal: Cardiol Young Date: 2013-12 Impact factor: 1.093
Authors: V Padmanabhan; K Siefert; S Ransom; T Johnson; J Pinkerton; L Anderson; L Tao; K Kannan Journal: J Perinatol Date: 2008-02-14 Impact factor: 2.521
Authors: Carl Bose; Linda J Van Marter; Matthew Laughon; T Michael O'Shea; Elizabeth N Allred; Padmani Karna; Richard A Ehrenkranz; Kim Boggess; Alan Leviton Journal: Pediatrics Date: 2009-08-17 Impact factor: 7.124
Authors: Camilia R Martin; Yolanda F Brown; Richard A Ehrenkranz; T Michael O'Shea; Elizabeth N Allred; Mandy B Belfort; Marie C McCormick; Alan Leviton Journal: Pediatrics Date: 2009-07-27 Impact factor: 7.124
Authors: Anna Maria Marconi; Stefania Ronzoni; Patrizia Bozzetti; Simona Vailati; Alberto Morabito; Frederick C Battaglia Journal: Obstet Gynecol Date: 2008-12 Impact factor: 7.661